Concepedia

Sylwia Olejniczak

SO

7

Publications

161

Citations

7

H-Index

2017

Active since

Affiliations

OncoArendi Therapeutics (Poland)(Current)

International Institute of Molecular and Cell Biology

Sylwia Olejniczak is an author at OncoArendi Therapeutics (Poland) specializing in drug discovery, drug development, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2017–2024

7

Publications

7

Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma

Marzena Mazur, Jacek Olczak, Sylwia Olejniczak et al. · Journal of Medicinal Chemistry · 2017 · 35 citations · Full text

Discovery of <b>OATD-01</b>, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis

Robert Koralewski, Barbara Dymek, Marzena Mazur et al. · Journal of Medicinal Chemistry · 2020 · 29 citations · Full text

Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases

Marzena Mazur, Barbara Dymek, Robert Koralewski et al. · Journal of Medicinal Chemistry · 2019 · 27 citations · Full text

Structure-Based Discovery of High-Affinity Small Molecule Ligands and Development of Tool Probes to Study the Role of Chitinase-3-Like Protein 1

Wojciech Czestkowski, Łukasz Krzemiński, Michał Piotrowicz et al. · Journal of Medicinal Chemistry · 2024 · 23 citations · Full text

A New Inhibitor of Tubulin Polymerization Kills Multiple Cancer Cell Types and Reveals p21-Mediated Mechanism Determining Cell Death after Mitotic Catastrophe

Mykola Zdioruk, Andrew Want, Anna Mietelska‐Porowska et al. · Cancers · 2020 · 22 citations · Full text

Rows per page

1–5 of 7